Inmate Central

Inmate Central, where civil and family-friendly discourse about off-audio topics (other than religion and politics) is welcome.

For Sale Ads

FAQ / News / Events

Use this form to submit comments directly to the Asylum moderators for this forum. We're particularly interested in truly outstanding posts that might be added to our FAQs.
You may also use this form to provide feedback or to call attention to messages that may be in violation of our content rules.

You must login to use this feature.

Inmate Login

By default, logging in will set a session cookie that disappears when you close your browser. Clicking on the 'Remember my Moniker & Password' below will cause a permanent 'Login Cookie' to be set.

Moniker/Username: The Name that you picked or by default, your email. Forgot Moniker?	Examples "Rapper", "Bob W", "joe@aol.com".
Password:	Forgot Password?
	Remember my Moniker & Password ( What's this?)

If you don't have an Asylum Account, you can create one by clicking Here.

Our privacy policy can be reviewed by clicking Here.

Inmate Comments

From:
Your Email:
Subject:

Message Comments

Original Message

"--"apparently not interesting enough"--to justify . .."

Posted by Krav Maga on August 19, 2020 at 16:36:54:
"So, the title is correct--"apparently not interesting enough"--to justify the tremendous expenditure necessary to gain regulatory approval for use as a registered pharmaceutical."

My point, which apparently, in hindsight, I should have made clearer, was that Big Pharma would have little interest in providing funding for proper RCTs for vitamin D, a drug which is already a registered pharmaceutical. There's nothing in it for them.
In this case, researchers would be better off pursuing funding from billionaires like Bill Gates or his foundation or the like.
Of course, funding for RCTs could also come from the National Institutes of Health, the Department of Defense, or the Department of Veteran's Affairs.